Browse by author
Lookup NU author(s): Professor Alan Boddy,
Professor Andrew Pearson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The pharmacological effects of ifosfamide (IFO) are dependent on its metabolism which may vary between different modes of administration. This was studied in 17 patients who received both a continuous infusion (9 g/m(2) over 72 h) and repeated bolus administration (3 g/m(2) every 24 h for 3 days). Concentrations of IFO and its metabolites were determined in plasma and urine. There was up to 70% less of the dechloroethylated metabolites in plasma following bolus administration compared to continuous infusion. Since dechloroethylation results in the formation of the toxic metabolite chloroacetaldehyde, this difference in metabolism may have an impact on the toxicity of IFO. There were no other consistent differences between the two modes of administration. Autoinduction of IFO metabolism, with an increase in dechloroethylated metabolites, was observed for both modes of administration. In conclusion, apart from dechloroethylation, there is little difference between these two modes of administration. However, during multiple cycles of IFO therapy such differences could have a significant effect.
Author(s): Boddy, A. V., Yule, S. M., Wyllie, R., Price, L., Pearson, A. D. J., Idle, J. R.
Publication type: Article
Publication status: Published
Journal: European Journal of Cancer
ISSN (print): 0959-8049
ISSN (electronic): 1879-0852
PubMed id: 7640054
Altmetrics provided by Altmetric